NCT04325555View on ClinicalTrials.gov

Pre-exposure Prophylaxis: A Miracle Drug or a Moral Hazard

CompletedOBSERVATIONAL

Enrollment

2,647

Participants

Timeline

Start Date

January 20, 2020

Primary Completion Date

March 15, 2020

Study Completion Date

March 15, 2020

Conditions

SyphilisChlamydiaGonorrheaSexually Transmitted Diseases

Interventions

DRUG

PrEP

The investigators measure self-reported PrEP status as exposure, i.e., PrEP status is not confirmed via matched medical records or any other type of information directly collected form subjects.

Trial Locations (1)

00000

New York University Abu Dhabi, Abu Dhabi

All Listed Sponsors

lead

New York University

OTHER

NCT04325555 - Pre-exposure Prophylaxis: A Miracle Drug or a Moral Hazard | Biotech Hunter | Biotech Hunter